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Abstract
Background
Handwriting in Parkinson’s disease (PD) features specific abnormalities which are difficult to
assess in clinical practice since no specific tool for evaluation of spontaneous movement is
currently available.
Objective
This study aims to validate the ‘Systematic Screening of Handwriting Difficulties’ (SOS-test)
in patients with PD.
Methods
Handwriting performance of 87 patients and 26 healthy age-matched controls was exam-
ined using the SOS-test. Sixty-seven patients were tested a second time within a period of
one month. Participants were asked to copy as much as possible of a text within 5 minutes
with the instruction to write as neatly and quickly as in daily life. Writing speed (letters in 5
minutes), size (mm) and quality of handwriting were compared. Correlation analysis was
performed between SOS outcomes and other fine motor skill measurements and disease
characteristics. Intrarater, interrater and test-retest reliability were assessed using the intra-
class correlation coefficient (ICC) and Spearman correlation coefficient.
Results
Patients with PD had a smaller (p = 0.043) and slower (p<0.001) handwriting and showed
worse writing quality (p = 0.031) compared to controls. The outcomes of the SOS-test signif-
icantly correlated with fine motor skill performance and disease duration and severity. Fur-
thermore, the test showed excellent intrarater, interrater and test-retest reliability (ICC >
0.769 for both groups).
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Conclusion
The SOS-test is a short and effective tool to detect handwriting problems in PD with excel-
lent reliability. It can therefore be recommended as a clinical instrument for standardized
screening of handwriting deficits in PD.
Introduction
Writing problems often manifest themselves as the first symptom of Parkinson’s disease (PD).
Although generally known as micrographia, i.e. ‘an impairment of a fine motor skill manifesting
mainly as a progressive or stable reduction in amplitude during a writing task ‘[1], writing prob-
lems in PD can be more complex. They often include timing deficits, irregularities and break-
down of movement, as well as loss of amplitude [2–5]. Furthermore, different patients display
varying degrees of variability in timing and/or amplitude, e.g. presenting as either a global
reduction (consistent) or a gradual reduction in writing size (progressive) [6]. Therefore, a
shift in terminology from micrographia to dysgraphia was recently suggested by Lettaneux
et al. [4]. As handwriting is an important daily activity, writing problems constitute an impor-
tant impairment of manual dexterity in daily life [1, 7].
A valid screening instrument that can assess and monitor these different components and
can detect changes of performance in a clinical setting is currently lacking. To assess tremor, bra-
dykinesia and rigidity, spiral drawings or tracking of pre-drawn figures have been used so far [8–
10]. As these tasks rely on the continuous provision of feedback and are novel rather than auto-
mated, they are unlikely to reflect true writing [11]. Furthermore, these tasks do not include the
more complex nature of the handwriting process, which incorporates both automated and con-
trolled processes [12]. Recently, Smits et al. used a digitizer pen to record pen tip trajectories to
assess movement time, velocity and size, as well as rest tremor during repeated character ’elelelel’
and sentence writing [13]. As this approach required a specific digitizer pen, a toolkit was devel-
oped to assess static signatures of patients with PD [14]. However, due to the nature of a signa-
ture, usually comprising of one word, it is not possible to determine whether writing deficits are
progressive. Although technology can provide detailed quantitative analyses of handwriting, not
all clinicians will have access to it and the use of technology will often require an investment.
To accommodate the problems with existing evaluation methods for handwriting in PD, the
validity of the ‘Systematic Screening of Handwriting Difficulties (SOS)’ was studied. This
screening tool was originally developed to detect early writing problems in children and was
composed of the six most sensitive items of the “Beknopte beoordelingsmethode voor kinder-
handschriften (BHK)” [15]. It not only evaluates writing amplitude and velocity, but also addi-
tional writing parameters contributing to the quality of handwriting. The SOS-test is an easy-to-
use test and only requires a blank page, pen and timer, making it feasible for use in daily prac-
tice. In this study, we aimed to investigate the construct validity of the SOS-test and whether it
can discriminate between patients with PD and healthy controls. Secondly, we examined
whether the SOS-test is a reliable tool by means of intrarater, interrater and test-retest analyses.
Materials and methods
Participants
In this cross-sectional study 87 patients with PD and 26 healthy controls were tested. Inclusion
criteria for patients were: (i) diagnosis of PD according to the ‘UK Brain Bank Criteria’; (ii)
Validation of the SOS-test for PD
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Hoehn and Yahr (H&Y) stage I-IV in the on-phase of the medication cycle [16]; (iii) Mini-
Mental State Examination (MMSE)> 24 [17]; and (iv) stable medication regimen. Participants
were excluded in case of (i) interfering medical upper limb problems, such as arthritis or
recent fractures of the hand; and (ii) the presence of a neurological disorder other than PD.
The study design and protocol were approved by the local Ethics Committee of the Univer-
sity Hospitals Leuven in accordance with The Code of Ethics of the World Medical Association
(Declaration of Helsinki). After a full explanation of the procedure and prior to testing, written
informed consent was obtained from all participants.
Procedure
All participants performed the Dutch version of the SOS-test to assess daily life writing (also
available in English and German) [15]. To assess construct validity, other fine motor skills were
evaluated using the Manual Ability Measure (MAM-16) questionnaire[18] and Purdue Peg-
board test [19]. In addition, the Edinburgh Handedness Inventory was completed [20]. Disease
specific characteristics were evaluated using the Movement Disorder Society Unified Parkin-
son’s Disease Rating Scale part III (MDS-UPDRS-III) [21], and the H&Y staging scale. Sixty-
seven of the 87 PD patients performed the SOS-test a second time, at least one week and at the
most one month after the first test to determine test-retest reliability. Patients were tested during
the on-phase of the medication cycle, i.e. approximately one hour after last medication intake.
We chose to test patients during the on-phase, as this closely resembles the clinical practice.
Patients were tested either at home or at the faculty of Rehabilitation Sciences of KU Leuven, a
situation which was kept constant for each participant. Also, patients were tested at the same
time of day on both test occasions and medication regimes did not change between tests.
Systematic screening of handwriting difficulties
For the SOS-test, all participants received a printed text, along with a blank piece of paper to
copy the text. Participants used a normal pen and the use of erasers was not allowed. During
five minutes, participants had to copy as much as possible of the given text with the instruction
to write as quickly and neatly as in daily life. Two different standard texts were used to avoid
learning effects for the test-retest evaluation.
Mean writing size, writing speed and the quality of handwriting were determined. Writing
speed was obtained by counting all letters written within five minutes, including letters that
were crossed out. The first five lines, each containing one sentence, were used to evaluate the
quality of handwriting, based on five criteria (Fig 1): (i) fluency in letter formation; (ii) connec-
tions between letters; (iii) regularity of letter size; (iv) space between words; and (v) straightness
Fig 1. The SOS-test. (A) Example of a Dutch SOS-test of a patient with PD; (B) The subitems of the quality
score in English. The arrows and horizontal lines indicate where problems were detected.
doi:10.1371/journal.pone.0173157.g001
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of the sentence. The total SOS-score was the sum of the scores on the five criteria, with higher
scores reflecting worse quality of handwriting. Each criterion received a score ranging from
zero to two. A score of zero was given when the handwriting problem did not occur or was only
present in one sentence. A score of one was given if the problem appeared in two or three sen-
tences and a score of two when the problem occurred in more than three sentences. Contrary to
the scoring of the test for children, mean handwriting size was not incorporated into the total
SOS-score as for PD the assumption that smaller handwriting reflects better performance is not
applicable. The mean handwriting size (mm) was assessed separately, using the standardized
template based on the first five lines.
Statistical analyses
Two raters (EN and EH), blinded to the other rater’s results and disease status of the subjects,
scored 180 copies (87 patients, 26 controls and 67 patients at re-test) of the SOS-test twice.
Intrarater reliability was determined for both raters by comparing the first and second scoring.
Interrater reliability was determined using the first scoring of both raters. Test-retest reliability
was assessed for 67 patients with PD and was based on the first scoring of test one and two by
the first rater (EN).
Normality of the data was assessed by means of QQ-plots, and histograms. Depending on
the distribution, general characteristics of patients with PD and healthy controls were com-
pared using an independent t-test or the non-parametric Mann-Withney-U test. For compari-
son of gender the Chi-squared test was used. Main outcomes of the SOS-test, i.e. score, size
and speed, were compared between groups using a one-way ANCOVA with gender as a covar-
iate, as this differed significantly between groups and has been shown to influence handwriting
[22]. The assumption of normality was assessed by means of Q-Q plots, while the Levene’s test
was used to determine equality of variances. Differences between groups for the subitems of
the SOS-score, i.e. fluency, connections, regularity, space and straightness, were assessed by
means of a Chi-squared test. Additionally, an exploratory subgroup analysis was done compar-
ing patients with corresponding side of disease onset and writing hand (= congruent, N = 59)
to patients with differing side of onset and writing hand (= incongruent, N = 28) for the main
SOS-outcome variables.
Construct validity was assessed by correlating the main SOS outcomes (score, size and
speed) with other measures for fine motor skills shown to differ between patients with PD and
healthy controls, i.e. Purdue Pegboard and MAM-16 [23, 24], using Spearman correlation
analysis for patients and controls separately. To investigate the possibility that cognition is
reflected in the writing process, the main SOS outcomes were correlated with the MMSE
scores. False Discovery Rate (FDR) corrections were applied to correct for multiple testing. In
addition, for patients a Spearman correlation analysis was performed with clinical characteris-
tics, i.e. disease duration, H&Y stage, total MDS-UPDRS-III and upper limb items of the
MDS-UPDRS-III. For the latter score items 3.4, 3.5, 3.6, 3.15 and 3.16 were used. Additionally,
an exploratory analysis was performed in which a distinction was made between sequential
upper limb items (3.4–3.6) and tremor-related upper limb items (3.15–3.16). FDR-corrections
were applied to correct for multiple testing.
Paired t-tests and Wilcoxon signed rank tests were used to look for systematic differences
within and between raters and between test moments. Intrarater, interrater and test-retest reli-
ability were evaluated using the Intraclass Correlation Coefficient (ICC) for single measures in
a two-way random effects model with absolute agreement for the total SOS-score, size and
speed. For interpretation of the ICC the criteria from Shrout and Fleiss were used, with<0.40
as poor, 0.40–0.75 as fair to good and>0.75 as excellent reliability [25]. In case of normal
Validation of the SOS-test for PD
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distribution, the standard error of measurement (SEM ¼ SDpooled 
ffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffi
ð1   ICCÞ
p
) and mini-
mal detectable change (MDC ¼ SEM  1:96
ffiffiffi
2
p
) were calculated. In case of abnormally
distributed data, Spearman correlation coefficients were used to indicate reliability. Landis and
Koch’s cutoffs were used for interpretation [26]. Bland Altman plots were constructed to visu-
alize the mean difference between two raters or tests for SOS score, size and speed.
For the sub-items of the quality score, Wilcoxon signed rank tests were used to look for sys-
tematic differences and Cohen’s kappa coefficient to evaluate the intrarater, interrater, and
test–retest reliability using the Landis and Koch benchmarks [26]. In addition, the percentage
of agreement was calculated. SPSS (version 23) was used for all analyses. The significance level
was set at p<0.05 for all tests.
Results
Subjects
Demographics and clinical characteristics of the participants are specified in Table 1. Groups
did not differ for age, handedness and MMSE score. There was a significant difference between
groups for gender and fine motor skills, as measured by the MAM-16 (p<0.001) and Purdue
Pegboard test (all p<0.001). These indicated greater fine motor skill problems in PD compared
to healthy controls.
Group comparison and construct validity
When comparing PD patients and healthy controls, it was found that patients had a signifi-
cantly higher SOS-score (F(1, 110) = 4.751; p = 0.031; d = 0.502), indicative of worse handwrit-
ing quality, as well as a smaller writing size (F(1, 110) = 4.205; p = 0.043; d = -0.475) and slower
writing speed (F(1, 110) = 12.924; p< 0.001; d = -0.828) (Fig 2). Looking at the quality of
handwriting into more detail, it was found that writing fluency (χ2 = 15.486; p<0.001) and reg-
ularity of letter height (χ2 = 16.098; p<0.001) were the items discriminating most between
Table 1. General Characteristics.
PD (N = 87) CT (N = 26) p-value
Age (years) 66 (58, 71) 62 (54, 71) 0.587
Gender (♂/♀) 61 / 26 8 / 18 <0.001
Edinburg Handedness Inventory (%) 100 (88.9, 100) 100 (90, 100) 0.406
MMSE (0–30) 29 (28, 30) 29 (29, 30) 0.110
MAM-16 (0–64) 59 (55.5, 61) 64 (64, 64) <0.001
Purdue Dominant hand 9.2 ± 2.7 13.0 ± 2.2 <0.001
Purdue Non-dominant hand 9.1 ± 2.2 12.5 ± 2.3 <0.001
Purdue Both hands 13.4 ± 4.4 20.5 ± 4.7 <0.001
Purdue Combination 15.7 ± 4.9 25.6 ± 7.1 <0.001
Disease duration (years) 6 (2, 10) - -
H&Y (1–5) 2 (2, 2) - -
MDS-UPDRS-III (0–132) 28.4 ± 14.0 - -
LED (mg/24h) 484.8 ± 335.9 - -
In case of normal distribution and equality of variances Mean ± standard deviation is presented, otherwise Median (first, third quartile) is displayed.
Abbreviations: CT = healthy control; H&Y = Hoehn & Yahr stage; LED = Levodopa Equivalent Dose; MAM-16 = Manual Ability Measure;
MDS-UPDRS-III = Movement Disorder Society Unified Parkinson’s Disease Rating Scale part III; MMSE = Mini Mental State Examination;
PD = Parkinson’s disease.
doi:10.1371/journal.pone.0173157.t001
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patients and controls with higher scores for patients. No significant differences were found for
connections between letters, space between words or straightness of the sentence (all
p>0.300).
The exploratory analysis, comparing patients depending on their side of onset, only revealed
that the congruent group wrote more slowly compared to the incongruent group (t = -2.398;
p = 0.019). No significant differences were found for handwriting quality or size.
Significant correlations, ranging from poor to moderate, showed that a higher SOS-score,
smaller writing size and slower writing speed all correlated with worse fine motor skills, as
measured by the Purdue Pegboard test, in patients with PD (Table 2). In healthy controls,
slower writing speed also correlated with worse performance on the Purdue Pegboard test
(Table 2). Additionally, a significant correlation was found between the MMSE score and writ-
ing speed in PD patients, with slower writing in more cognitively challenged patients. Further-
more, in patients a higher SOS-score correlated moderately with a longer disease duration,
worse overall disease severity (MDS-UPDRS-III total score) and upper limb tremor severity
(items 3.15–3.16 of the MDS-UPDRS-III) (Table 2). In addition, writing more slowly was
moderately correlated with a worse disease severity (H&Y and MDS-UPDRS-III total score)
and difficulties with sequential upper limb movements (items 3.4–3.6 of the MDS-UPDR-
S-III). Finally, writing size tended to decrease with increasing H&Y stage.
Reliability analysis
Bland and Altman plots are presented in S1 Fig for both interrater and test-retest analysis of
the SOS-tests of patients with PD. No bias could be detected, as points distributed equally
around zero for SOS-score, size and speed. For the SOS-score and size, overall scores fell
within the limits of agreement. With regards to speed, two points were outside the limits of
agreement in the interrater analysis. In addition, the limits of agreement were larger for test-
retest analysis.
Interrater reliability was excellent for SOS-score and speed for both the patient and control
group (Table 3). Spearman correlation coefficients for writing size were also very good. More
Fig 2. Difference between patients (PD) and healthy controls (CT). (A) SOS score; (B) size; (C) and
speed. ** p < 0.01; *** p < 0.001.
doi:10.1371/journal.pone.0173157.g002
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detailed analysis revealed that rater 1 gave a significantly lower SOS-score and larger size for both
groups compared to rater 2 with small to medium effect sizes. No systematic difference was
found for speed. Test-retest reliability was also excellent for SOS-score and speed with a very high
Spearman correlation coefficient for writing size. No systematic differences were observed
between sets of scores (Table 3). For intrarater reliability a comparable pattern could be observed
for both raters, with excellent reliability for SOS-score, size and speed for both groups (S1 Table).
Reliability of the sub-items of the quality score ranged from slight to almost perfect agree-
ment, with agreement percentages ranging from 48–100% (Table 4). Detailed analysis showed
a discrepancy between the Kappa statistic (0.115) and percentage agreement (91.558%) for the
interrater reliability of the item of word space in PD. As 141 out of 154 SOS-tests received a
score of zero from both raters, data distribution influenced the final Kappa statistic.
Discussion
The present study was conducted to validate the SOS-test for PD and to evaluate whether it is a
useful test to detect and monitor writing difficulties. An important innovative feature of this
test is that it evaluates natural writing, addressing internally generated motor performance
which is typically affected by PD. In addition, it only takes five minutes to complete and very
little material is necessary, making it a useful standardized screening tool for clinical practice.
Construct validity
Clear differences were observed between patients with PD and healthy controls with regards to
SOS-score, size and speed, with patients performing worse on all three aspects, even though
Table 2. Correlation analysis.
Parameter SOS score SOS speed SOS size
PD CT PD CT PD CT
Fine motor and cognitive skills
MAM-16 NS NS NS NS 0.203(*) NS
Purdue
Dominant hand NS NS 0.420*** NS 0.200(*) NS
Non-dominant hand -0.265* NS 0.291* 0.481(*) NS NS
Both hands -0.374** NS 0.324** 0.626* NS NS
Combination -0.297* NS 0.414*** 0.569* 0.266* NS
MMSE NS NS 0.425*** NS NS NS
PD specific
Disease duration 0.269* - NS - NS -
H&Y stage NS - -0.266* - -0.222(*) -
MDS-UPDRS-III
Total 0.276* - -0.376** - NS -
UL NS - -0.302* - NS -
UL sequential NS - -0.260* - NS -
UL tremor 0.301* - NS - NS -
Abbreviations: H&Y = Hoehn and Yahr stage; MAM-16 = Manual Ability Measure; MDS-UPDRS-III = Movement Disorder Society Unified Parkinson’s
Disease Rating Scale part III; NS = not significant; PD = Parkinson’s disease; SOS = Systematic Screening of Handwriting Difficulties; UL = upper limb.
(*) p < 0.1
*p < 0.05
** p < 0.01
*** p < 0.001, FDR-corrected for multiple testing
doi:10.1371/journal.pone.0173157.t002
Validation of the SOS-test for PD
PLOS ONE | DOI:10.1371/journal.pone.0173157 March 2, 2017 7 / 14
they were optimally medicated at the time of testing. Contrary to previously used evaluation
methods [8–10, 14], the SOS-test evaluates prolonged writing, increasing the chance of captur-
ing the automaticity deficit observed in PD [27]. Automatic movements have undergone a
considerable amount of practice and are executed without attention directed towards the
details of the movements. This type of habitual movement is known to highly rely on the func-
tioning of the striatum, explaining the PD-specific difficulties as striatal dopamine depletion is
a disease hallmark [28].
Analysis of the quality items revealed that fluency in writing and regularity of letter height
were more affected in PD. The latter is in line with earlier findings, based on tablet technology,
showing increased variability of writing size and decreasing letter height during writing in
patients with PD while both in the on- and off-phase of the medication cycle [29–31]. Even
though writing fluency in the current study was determined by means of sudden changes in
movement directions, difficulties with writing fluency were shown previously in PD by means
of an increased normalized jerk during writing-like movements [4, 32, 33]. Furthermore, it has
to be noted that difficulties with fluency could be attributed to upper limb tremor, as 68 out of
87 patients presented with upper limb tremor. No significant differences were found for transi-
tions between letters, the space between words or straightness of the sentences, which is in line
with expectations, as these problems were also not reported earlier in PD raising the question
whether these items may be redundant.
A correlation analysis was carried out to examine construct validity of the SOS-test. Weak
to moderate correlations were found between the three main SOS outcome parameters and
Table 3. Reliability analysis of SOS-test main outcome variables.
Parameter
SOS
Test/Rater 1 Mean
(SD)
Test/Rater 2 Mean
(SD)
t value p-value Effect
size
ICC (95% CI) SEM MDC
Interrater reliability
PD
Speed 367.7 ± 116.1 368.3 ± 115.8 1.536 0.127 -0.006 0.999 (0.999–1.000) 3.667 10.164
Score 3.5 ± 1.4 4.1 ± 1.9 5.292 0.000 -0.354 0.769 (0.633–0.848) 0.800 2.218
CT
Score 2.5 ± 1.4 3.5 ± 2.0 4.136 0.000 -0.783 0.783 (0.273–0.919) 0.805 2.231
Test–retest reliability
Speed 361.2 ± 119.2 368.0 ± 120.0 -1.268 0.209 0.057 0.965 (0.943–0.979) 22.374 62.018
Score 3.5 ± 1.3 3.5 ± 1.5 -0.108 0.915 0.007 0.806 (0.685–0.881) 0.618 1.712
Test/Rater 1 Median
(IQR)
Test/Rater 2 Median
(IQR)
Wilcoxon z
value
p-value Effect
size
Spearman correlation
coefficient
Interrater reliability
PD
Size 2.5 (2.0–2.5) 2.0 (2.0–2.5) -4.897 0.000 -0.279 0.860
CT
Speed 492.0 (362.3–533.0) 492.0 (363.0–533.0) -0.431 0.666 -0.060 1.000
Size 2.5 (2.5–3.0) 2.5 (2.0–3.0) -1.848 0.065 -0.256 0.805
Test–retest reliability
Size 2.5 (2.0–2.5) 2.0 (2.0–2.5) -0.866 0.386 -0.075 0.807
Measurement units: SOS score = unit less (0–10); SOS speed = letters written in 5 minutes; SOS size = mm. Abbreviations: CT = healthy control;
ICC = Intraclass Correlation Coefficient; IQR = interquartile range; SD = standard deviation; SEM = Standard Error of Measurement; MDC = Minimal
Detectable Change; SOS = Systematic Screening of Handwriting Difficulties; PD = Parkinson’s disease; 95% CI = 95% confidence interval. All ICC and
Spearman correlation coefficients were significant at p < 0.001
doi:10.1371/journal.pone.0173157.t003
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measures of manual dexterity. Writing is a complex motor skill that can be categorized as a
form of manual dexterity, which is impaired in PD [24, 31]. However, the current results also
show that writing performance has distinct components that are different from other fine
motor skills. While writing is considered an automatically performed movement, the placing
of pegs in the holes during the Purdue Pegboard test could be considered more goal-directed
[28]. In addition, worse writing performance, specifically writing quality and speed, proved
correlated with a longer disease duration and greater disease severity, confirming previous
findings [1]. However, correlations in the current study were moderately high and there was
merely a tendency towards a correlation between writing size and disease progression. One
possible explanation is that even though patients from H&Y stage I-IV were included, 75.9%
of patients were classified as H&Y stage II, while just 11.5% were in stage I, 11.5% in stage III
and 1.1% in stage IV. As such, the more severe patients with PD were probably under-repre-
sented in this cohort. Interestingly, the SOS score correlated positively with the upper limb
tremor-items of the MDS-UPDRS-III, while there was a negative correlation between SOS
speed and the items on sequential upper limb movement. Both correlations, however, point
towards a good construct validity of the SOS-test. A correlation between writing performance
on the SOS-test and cognition was also investigated, as cognitive difficulties are common in
PD, even in the early stages [34, 35]. We found that when patients experienced more cognitive
difficulties, writing slowed down. Working memory plays an important role in the handwrit-
ing process [36]. As working memory capacity was shown to be reduced in PD, this could
explain why patients with lower MMSE scores wrote more slowly [37, 38]. Although no longer
Table 4. Reliability analysis of subitems of the SOS quality score.
Parameter Test/Rater 1 Median (IQR) Test/Rater 2 Median (IQR) Wilcoxon z value p-value Kappa (95% CI) Agreement (%)
Interrater reliability
PD
Fluency 1.0 (1.0–2.0) 2.0 (1.0–2.0) -3.584 0.000 0.209 (0.093–0.325)*** 48.052
Connections 1.0 (1.0–2.0) 1.5 (1.0–2.0) -3.194 0.001 0.438 (0.326–0.550)*** 62.987
Regularity 1.0 (1.0–2.0) 1.0 (0.0–2.0) -1.218 0.223 0.470 (0.366–0.574)*** 63.636
Word space 0.0 (0.0–0.0) 0.0 (0.0–0.0) -3.606 0.000 0.115 (-0.016–0.246)* 91.558
Straightness 0.0 (0.0–0.0) 0.0 (0.0–0.0) -0.707 0.480 0.393 (0.219–0.567)*** 79.221
CT
Fluency 0.0 (0.0–1.0) 1.0 (0.0–2.0) -3.286 0.001 0.259 (0.047–0.471)* 50.000
Connections 1.0 (1.0–2.0) 2.0 (1.0–2.0) -1.667 0.096 0.391 (0.099–0.683)** 65.385
Regularity 0.0 (0.0–1.0) 0.0 (0.0–1.0) -1.134 0.257 0.508 (0.232–0.784)*** 73.077
Word space 0.0 (0.0–0.0) 0.0 (0.0–0.0) -1.000 0.317 1.000 (1.000–1.000)*** 96.154
Straightness 0.0 (0.0–1.0) 0.0 (0.0–0.0) -1.000 0.317 0.570 (0.202–0.938)** 84.615
Test–retest reliability
Fluency 1.0 (0.0–2.0) 1.0 (1.0–2.0) -1.300 0.194 0.407 (0.231–0.583)*** 61.194
Connections 1.0 (1.0–2.0) 1.0 (1.0–2.0) -1.633 0.102 0.439 (0.255–0.623)*** 64.179
Regularity 1.0 (1.0–1.0) 1.0 (1.0–1.0) -0.536 0.592 0.407 (0.223–0.591)*** 62.687
Word space 0.0 (0.0–0.0) 0.0 (0.0–0.0) 0.000 1.000 1.000 (1.000–1.000)*** 100.000
Straightness 0.0 (0.0–0.0) 0.0 (0.0–0.0) -0.302 0.763 0.448 (0.185–0.711)*** 83.582
Abbreviations: CT = healthy control; IQR = interquartile range; PD = Parkinson’s disease; SOS = Systematic Screening of Handwriting Difficulties; 95%
CI = 95% confidence interval.
* p < 0.05
** p < 0.01
*** p < 0.001
doi:10.1371/journal.pone.0173157.t004
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significant after correction for multiple testing, healthy controls displayed a similar pattern, in
line with cognitive impairments found as a result of healthy aging [39]. Overall, these findings
point to the importance of intact cognition for writing speed and support the use of the SOS-
test as a multi-component test of writing quality, rather than representing velocity alone.
Finally, recent work from our group has shown that differences between patients with and
without freezing of gait can be detected with the SOS-test [29] and that the SOS-test is sensitive
enough to detect improvements in writing size after intensive amplitude training [40]. These
results suggest that the SOS-test can be used to monitor writing difficulties with time and
detect intervention effects in PD.
Reliability
Overall, results show an excellent intra- and interrater reliability for writing size and writing
speed in PD and healthy controls. This can most likely be attributed to the objective criteria
that are used for scoring, indicating that the SOS-test can be reliably used in both groups.
Analysis with Bland-Altman plots showed that, in general, points were distributed equally
around zero. Although the reliability of the overall quality score was excellent, the individual
items should be interpreted with caution, as reliability varied from slight to almost perfect
agreement.
Test-retest reliability in patients was excellent for the SOS-score, size and speed. Bland-Alt-
man plots showed that the limits of agreement were larger for writing speed. One possible
explanation is that this reflects the inherent variability of test performance due to fluctuations
of symptoms, as was recently also suggested for the Instrumented Timed Up and Go Test [41].
Study limitations and recommendations
The current study showed that the SOS-test can distinguish between patients with PD and
healthy controls, however, the correlations with disease severity were less clear. Therefore,
future research should include participants equally distributed over H&Y stages to investigate
whether the SOS-test is sensitive enough to detect disease progression. In addition, handwrit-
ing has been suggested as a possible non-invasive biomarker for PD diagnosis [7]. Therefore, it
would be interesting to include a newly-diagnosed de novo PD group in future studies to test
whether the SOS-test is sensitive enough to detect early deficits. For this purpose, it would be
necessary to assure consistency between side of onset and the hand with which the patient
writes, as results revealed slower handwriting in patients who write with the hand that was ini-
tially affected. An alternative calculation of the SOS quality score may be needed to detect the
differences between H&Y stages. For this purpose, we suggest to not only score whether or not
problems occur in a sentence, but also to take into account the number of problems in each
sentence. Scoring could also be made more sensitive by analyzing a larger portion of text. It
has to be noted that writing speed on the SOS-test is calculated as the number of letters written
in 5 min, while writing speed measured with specialized tablets is usually expressed in cm/s.
Previous work has shown strong correlations between writing speed on the SOS-test and on a
writing tablet [42, 43].
Secondly, recent research has suggested a partially different neural basis for consistent and
progressive micrographia [44]. This suggests that a different rehabilitation approach might be
necessary for either subtype. Further research is warranted to determine whether the SOS-test
can be used to detect this difference.
Finally, future work is needed to uncover the possibilities of combining spontaneous writ-
ing with digitized tablets or pens [13, 42, 43]. Work is ongoing to validate these tools, but auto-
mation of calibration and analysis procedures need further refinement to allow clinical
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implementation (unpublished data). For now, we recommend to use the SOS-test in clinical
practice with writing size as the main parameter for follow-up of PD patients due to the link
between writing size and legibility of handwriting and the improvements found after intensive
training. The quality score can provide additional information regarding fluency in letter for-
mation and regularity of letter size. Future work should determine whether omitting the seem-
ingly redundant items (word space and straightness of the sentence) would make the test more
PD-specific without losing information, which would also aid future digitized versions. Finally,
SOS writing speed is more informative about the degree of bradykinesia than handwriting legi-
bility as such.
Conclusion
We conclude that the SOS-test is a reliable tool with excellent construct validity, warranting its
use as a clinical handwriting test in PD. Future work needs to be done to refine the test and
make it even more specific for this population with the potential to serve as a diagnostic and
progression biomarker.
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